Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Commenced operations in flood-affected Himachal Pradesh
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Apollo Telehealth has established more than 700 centers, in 7 states
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Subscribe To Our Newsletter & Stay Updated
